Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 4—April 2004

Dispatch

West Nile Virus, Guadeloupe

René Quirin*, Michel Salas†, Stéphan Zientara‡, Hervé Zeller§, Jacques Labie‡, Séverine Murri§, Thierry Lefrançois*, Martial Petitclerc†, and Dominique Martinez*Comments to Author 
Author affiliations: *Centre de Coopération Internationale en Recherche Agronomique pour le Développement, Petit Bourg, Guadeloupe, French West Indies; †Direction des Services Vétérinaires de Guadeloupe, Basse Terre, Guadeloupe, French West Indies; ‡Agence Française de Sécurité Sanitaire des Aliments, Maison Alfort, France; and §Institut Pasteur, Lyon, France

Main Article

Table 1

West Nile virus IgGa antibody prevalence in horses in seven equine centers, Guadeloupe and Marie Galante, July 2002–January 2003

Place No. tested July 2002 Positive Prevalence % No. tested Jan 2003 Positive Prevalence % Seroconversion rate %
A
25
1
4.0
23
14
60.9
59.1
B
51
2
3.9
44
27
61.4
59.5
C
7
2
28.6
7
5
71.4
60.0
D
13
5
38.5
12
7
58.3
28.5
E



10b
2
20.0

F



2b
2
100.0

G
4
0
0.0
5
3
60.0
60.0
H
7
0
0.0
9
3
33.3
33.3
I
6
0
0.0
24
5
20.8
20.8
Total 113 10 8.8 136 68 50.0

     aIgG, immunoglobulin G.
     bImported after July 2002.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO